Back to search results

DapagliFLOzin in Renal AL Amyloidosis (FLORAL)

Abroad (travel likely)RecruitingPHASE2

Conditions

Renal AL Amyloidosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Karmanos Cancer Institute, Detroit, Michigan, United States

    Contact: Study coordinator (Christiane Houde) · Houdec@karmanos.org · 3135768673
    Contact: Study coordinator (Jeffrey Zonder) · zonderj@karmanos.org · 3135768732
    Contact: Principal Investigator (Jeffrey Zonder, M.D.)
    Andrew Kin, M.D. (Sub-investigator)
    Aditi Sharma, M.D. (Sub-investigator)
    Joel Topf, M.D. (Sub-investigator)
    Craig Cole, M.D. (Sub-investigator)
Study leads

  • Jeffrey Zonder, M.D.

    Principal Investigator

    Barbara Ann Karmanos Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)